We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$19.5B
AUM Growth
+$5.19B
(+36%)
Cap. Flow
+$4.12B
Cap. Flow
% of AUM
21.08%
Top 10 Holdings %
Top 10 Hldgs %
20.25%
Holding
3,398
New
1,285
Increased
656
Reduced
281
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$224M |
| 2 |
PayPal
PYPL
|
+$220M |
| 3 |
Kroger
KR
|
+$154M |
| 4 |
Zillow
Z
|
+$133M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$189M |
| 2 |
Freeport-McMoran
FCX
|
+$176M |
| 3 |
AbbVie
ABBV
|
+$171M |
| 4 |
Booking.com
BKNG
|
+$155M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.46% |
| 2 | Healthcare | 11.27% |
| 3 | Materials | 10.17% |
| 4 | Technology | 7.72% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Dynatrace
DT
$12.7B
| $1.5M | 0.01% |
39,080
+38,885
| +19,941% | +$1.41M |
|
502
Lennox International
LII
$18.9B
| $1.48M | 0.01% |
6,198
+4,849
| +359% | +$1.19M |
|
503
Ingredion
INGR
$6.48B
| $1.48M | 0.01% |
+15,120
| New | +$1.39M |
|
504
Paychex
PAYX
$42.3B
| $1.48M | 0.01% |
12,805
+1,302
| +11% | +$152K |
|
505
Halozyme
HALO
$9.9B
| $1.47M | 0.01% |
25,916
+20,021
| +340% | +$1.03M |
|
506
Tetra Tech
TTEK
$8.7B
| $1.47M | 0.01% |
50,750
+34,470
| +212% | +$996K |
|
507
Jefferies Financial Group
JEF
$13.2B
| $1.47M | 0.01% |
+44,892
| New | +$1.49M |
|
508
Lithia Motors
LAD
$8.17B
| $1.47M | 0.01% |
+7,168
| New | +$1.53M |
|
509
PBF Energy
PBF
$7.22B
| $1.46M | 0.01% |
35,799
-608,589
| -94% | -$25.3M |
|
510
Matador Resources
MTDR
$5.73B
| $1.46M | 0.01% |
25,460
+18,397
| +260% | +$1.16M |
|
511
NXP Semiconductors
NXPI
$65.4B
| $1.45M | 0.01% |
9,206
-56,149
| -86% | -$8.91M |
|
512
Ciena
CIEN
$49.6B
| $1.45M | 0.01% |
28,488
+28,386
| +27,829% | +$1.28M |
|
513
Manhattan Associates
MANH
$9.95B
| $1.45M | 0.01% |
11,942
+8,983
| +304% | +$1.1M |
|
514
First American
FAF
$8.08B
| $1.45M | 0.01% |
+27,675
| New | +$1.4M |
|
515
Acadia Healthcare
ACHC
$3.01B
| $1.44M | 0.01% |
+17,434
| New | +$1.44M |
|
516
Murphy Oil
MUR
$5.25B
| $1.43M | 0.01% |
33,208
+22,328
| +205% | +$1.01M |
|
517
Gentex
GNTX
$5.12B
| $1.43M | 0.01% |
+52,354
| New | +$1.4M |
|
518
Interactive Brokers
IBKR
$40.5B
| $1.43M | 0.01% |
+78,872
| New | +$1.47M |
|
|
SWAV
519
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.42M | 0.01% |
6,922
+5,842
| +541% | +$1.48M |
|
520
Curtiss-Wright
CW
$26.9B
| $1.42M | 0.01% |
+8,504
| New | +$1.42M |
|
521
MDU Resources
MDU
$4.31B
| $1.42M | 0.01% |
+123,010
| New | +$1.38M |
|
522
Royal Gold
RGLD
$16.6B
| $1.42M | 0.01% |
12,580
+11,599
| +1,182% | +$1.2M |
|
523
Capri Holdings
CPRI
$1.88B
| $1.41M | 0.01% |
24,678
+19,574
| +384% | +$989K |
|
524
DexCom
DXCM
$28.9B
| $1.41M | 0.01% |
12,472
-126,637
| -91% | -$13.9M |
|
525
Saic
SAIC
$5.14B
| $1.4M | 0.01% |
+12,613
| New | +$1.33M |
|
Similar funds
SAM
Pacer Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Pacer Advisors held 3,398 positions worth $19.5B, up 36% from $14.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Pacer Advisors deployed $4.12B of net new capital in Q4 2022, opening 1,285 new positions and adding to 656 existing holdings. Its largest new stake was Woodside Energy: 805,273 shares worth $19.5M.
By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $189M trimmed.
- Pacer Advisors's largest Q4 2022 buy was Woodside Energy: 805,273 shares worth $19.5M.
- Pacer Advisors added most to EOG Resources in Q4 2022, an estimated $224M increase.
- Pacer Advisors's biggest Q4 2022 reduction was Regeneron Pharmaceuticals, cutting an estimated $189M.
- Pacer Advisors fully exited Rithm Capital in Q4 2022, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 20% of its $19.5B portfolio in Q4 2022.
- Pacer Advisors opened 1,285 new positions and closed 56 in Q4 2022.
- Pacer Advisors's portfolio value rose 36% quarter-over-quarter to $19.5B.
Based on Pacer Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.